1-3 of 3
Yuichi Kato, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study Of Dasatinib In Chronic Phase Of Newly Diagnosed Chronic Myeloid Leukemia (CML-CP)

Yoji Ishida, M.D., Ph.D., Kazunori Murai, MD, PhD, Kohei Yamaguchi, M.D., Takuo Miyagishima, MD, PhD, Motohiro Shindo, M.D., Ph.D., Kazuei Ogawa, M.D., Ph.D., Takahiro Nagashima, MD, PhD, Shinji Sato, MD, PhD, Reiko Watanabe, M.D., Ph.D., Satoshi Yamamoto, MD, PhD, Takaaki Hirose, MD, PhD, Yuichi Kato, MD, PhD, Masakatsu Yonezumi, M.D. PhD, Takeshi Kondo, MD., PhD, Nobuo Mochizuki, PhD, Keiko Ohno, PhD, Satoshi Kishino, PhD, Shigeki Ito, M.D., Ph.D., Komei Kubo, MD, PhD, Sohichi Saito, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4031.
https://doi.org/10.1182/blood.V122.21.4031.4031
Published: 2013
Journal Articles

Multicenter Phase II Clinical Trial of Nilotinib for Patients with Imatinib-Resistant or Intolerant CML From the East Japan CML Study Group (EJCML) Trial: Evaluation of Molecular Responses by the BCR-ABL1 Mutational Status and Plasma Trough Concentration of Nilotinib

Naoto Takahashi, MD, PhD, Masatomo Miura, PhD, Jun Kuroki, MD, PhD, Kinuko Mitani, MD, PhD, Atsushi Kitabayashi, MD, PhD, Osamu Sasaki, MD, PhD, Hideo Kimura, MD, PhD, Kiyotoshi Imai, MD, PhD, Norifumi Tsukamoto, MD, PhD, Hideyoshi Noji, MD, PhD, Takeshi Kondo, MD, PhD, Akihisa Kuwayama, MD, PhD, Mutsuhito Motegi, MD, PhD, Yuichi Kato, MD, PhD, Kaoru Takahashi, MD, PhD, Masayuki Mita, MD, PhD, Hajime Saito, MD, PhD, Chikashi Yoshida, MD, PhD, Yoshihiro Torimoto, MD, PhD, Tomofumi Kimura, MD, PhD, Yuji Wano, MD, PhD, Jun Nomura, MD, PhD, Satoshi Yamamoto, MD, PhD, Ko Mayama, MD, PhD, Riko Honma, MD, PhD, Tomohiro Sugawara, MD, PhD, Shinji Sato, MD, PhD, Atsushi Shinagawa, MD, PhD, Akihiko Chubachi, MD, PhD, Hideo Harigae, MD, PhD, Kenichi Sawada, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1360.
https://doi.org/10.1182/blood.V120.21.1360.1360
Published: 2012
Journal Articles

Safety, Feasibility and Efficacy of High Dose Ranimustine (MCNU), Carboplatin, Etoposide, and Cyclophosphamide (MCVC) Therapy Followed by Autologous Stem Cell Transplantation for Malignant Lymphoma.

Yoshihiro Kameoka, MD, PhD, Naoto Takahashi, MD, PhD, Kenichi Ishizawa, MD, PhD, Kazunori Murai, MD, PhD, Yuichi Kato, MD, PhD, Hideyoshi Noji, MD, PhD, Jugo Ito, MD, PhD, Makoto Hirokawa, MD, PhD, Katsusi Tajima, MD, PhD, Tsutomu Shichishima, MD, PhD, Yoji Ishida, MD, PhD, Hideo Harigae, MD, PhD, Kenichi Sawada, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4588.
https://doi.org/10.1182/blood.V116.21.4588.4588
Published: 2010